Published in Ann Neurol on November 01, 1997
[Multiple sclerosis. An update with practical guidelines for ophthalmologists]. Ophthalmologe (2006) 0.75
[Optic disc swelling : A compilation of relevant differential diagnoses]. Ophthalmologe (2016) 0.75
[Papilledema with visual loss]. Ophthalmologe (2017) 0.75
Does Levodopa improve visual function in NAION? Ophthalmology (2000) 9.70
Screening depressed patients in family practice. A rapid technic. Postgrad Med (1972) 5.89
The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol (2001) 5.78
Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. Am J Ophthalmol (2001) 5.37
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med (2000) 4.50
The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology (1999) 3.23
Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group. Neurology (1992) 3.19
Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol (1993) 2.03
Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology (1984) 1.74
The Amblyopia Treatment Index. J AAPOS (2001) 1.68
A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter. Ophthalmology (1985) 1.64
The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci (2000) 1.61
Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome. Neurology (2007) 1.56
Cross-validation of the Suicidal Intent Scale. Psychol Rep (1974) 1.54
Cortical blindness: etiology, diagnosis, and prognosis. Ann Neurol (1987) 1.51
Observational study of subclinical diabetic macular edema. Eye (Lond) (2012) 1.49
Neuroretinitis in childhood. J Pediatr Ophthalmol Strabismus (1989) 1.43
The natural history of acute traumatic sixth nerve palsy or paresis. J AAPOS (1998) 1.34
Is there a racial difference in physiologic cup size? Ophthalmology (1985) 1.33
Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am J Ophthalmol (1996) 1.31
Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA (1993) 1.28
Orbital emphysema as an ophthalmologic emergency. Ophthalmology (1984) 1.17
Deficits in visual function after resolution of optic neuritis. Ophthalmology (1987) 1.16
Bilateral idiopathic inflammation of the optic nerve sheaths. Light and electron microscopic findings. Ophthalmology (1989) 1.15
Quantitative relation between emphysema and lung mineral content in coalworkers. Occup Environ Med (1994) 1.15
Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol (1994) 1.14
Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. Am J Ophthalmol (1999) 1.13
The incidence of extended households among middle-aged black and white women: estimates from a 15-year panel study. J Fam Issues (1989) 1.12
Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. Ann Neurol (1986) 1.03
The optic neuritis treatment trial: three-year follow-up results. Arch Ophthalmol (1995) 1.01
Design, methods, and conduct of the Optic Neuritis Treatment Trial. Control Clin Trials (1993) 1.01
Contrast sensitivity measurements in acute and resolved optic neuritis. Br J Ophthalmol (1984) 1.01
Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). Control Clin Trials (1993) 0.97
Iatrogenic Horner's syndrome secondary to chest tube thoracostomy. J Clin Neuroophthalmol (1983) 0.96
Molar growth yields in Streptococcus faecalis var. liquefaciens. J Bacteriol (1966) 0.95
Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial. J Neuroophthalmol (1997) 0.95
The optic neuritis treatment trial. Implications for clinical practice. Optic Neuritis Study Group. Arch Ophthalmol (1992) 0.95
Predictors of nonrecovery in acute traumatic sixth nerve palsy and paresis. Ophthalmology (2001) 0.93
The SKILL Card test in optic neuritis: experience of the Optic Neuritis Treatment Trial. Smith-Kettlewell Institute Low Luminance. Optic Neuritis Study Group. J Neuroophthalmol (2001) 0.93
Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis. Arch Neurol (1983) 0.93
Recall bias in a prospective cohort study of acute time-varying exposures: example from the herpetic eye disease study. J Clin Epidemiol (2001) 0.92
The Optic Neuritis Treatment Trial. Arch Ophthalmol (1988) 0.90
Pain in anterior ischemic optic neuropathy. J Neuroophthalmol (1995) 0.90
Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis. J AAPOS (2000) 0.89
Familial recurrent Bell's palsy with ocular motor palsies. Neurology (1987) 0.89
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. Neurology (2000) 0.88
Acute ischemic optic neuropathy in severe preeclampsia. Am J Ophthalmol (1980) 0.86
Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin. Exp Clin Endocrinol Diabetes (2007) 0.86
Decreased visual acuity from optic disc drusen. Arch Ophthalmol (1985) 0.85
The Pediatric Eye Disease Investigator Group. J AAPOS (1998) 0.85
Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology (1996) 0.84
Caries prevalence in Head Start children, 1986-87. J Public Health Dent (1990) 0.84
Involvement of the optic chiasm, optic tract and geniculo-calcarine visual system in multiple sclerosis. Bull Soc Belge Ophtalmol (1983) 0.83
Iris ischemia following surgery on two rectus muscles. Arch Ophthalmol (1985) 0.82
The effect of alcohol and smoking on testosterone function and aggression in chronic alcoholics. Am J Psychiatry (1977) 0.82
Control of familywise errors in multiple endpoint assessments via stepwise permutation tests. Stat Med (1996) 0.81
The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Optic Neuritis Study Group. Neurology (1998) 0.81
Suicide notes and risk of future suicide. JAMA (1974) 0.80
Pattern flash visual evoked potentials in patients with homonymous hemianopia. Doc Ophthalmol (1992) 0.80
Traumatic orbital encephalocele. Can J Ophthalmol (1989) 0.80
Post-decompression optic neuropathy. J Neurosurg (1985) 0.79
Occurrence and Distribution of Proteinase of Streptococcus faecalis var. liquefaciens. J Bacteriol (1966) 0.79
The changing role of MR imaging in the evaluation of acute optic neuritis. Radiology (1994) 0.79
Cataract progression in India. Br J Ophthalmol (1997) 0.79
The optic neuritis treatment trial: implications for clinicians. Semin Ophthalmol (1995) 0.79
Activities of arginine dihydrolase and phosphatase in Streptococcus faecalis and Streptococcus faecium. Appl Microbiol (1968) 0.78
Amblyopia. Current clinical studies. Ophthalmol Clin North Am (2001) 0.78
Internuclear ophthalmoplegia after head trauma. Ann Ophthalmol (1981) 0.78
Automated perimetry: principles and practice. Int Ophthalmol Clin (1986) 0.78
Functional disease in neuro-ophthalmology. Neurol Clin (1983) 0.78
Atonic pupil after cataract surgery. Ophthalmology (1989) 0.78
Lack of interaction between Sendai virus and bacterial cells. Proc Soc Exp Biol Med (1972) 0.77
Orbital involvement in mycosis fungoides. Arch Ophthalmol (1984) 0.77
Melioidosis and bilateral third-nerve palsies. Neurology (1984) 0.77
What to tell the patient with optic neuritis about multiple sclerosis. Surv Ophthalmol (1991) 0.76
Recovery from severe visual loss in optic neuritis. Arch Ophthalmol (1993) 0.76
Anterior ischaemic optic neuropathy: recurrent episodes in the same eye. Br J Ophthalmol (1983) 0.76
Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) (2000) 0.75
Risk factors for postoperative endophthalmitis. Ophthalmology (1992) 0.75
Effect of a transient, geographically localised economic recovery on community health and income studied with longitudinal household cohort interview method. J Epidemiol Community Health (1998) 0.75
Treatment of Graves' ophthalmopathy. N Engl J Med (1990) 0.75
Vigabatrin-associated retinal cone system dysfunction. Neurology (1998) 0.75
Properties of aldolase from Francisella tularensis. J Bacteriol (1971) 0.75
Optic neuritis or anterior ischemic optic neuropathy? Arch Ophthalmol (1992) 0.75
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis. Lancet (1997) 0.75
Is donor age an important determinant of graft survival? Cornea (2000) 0.75
A phase II study of IV methylprednisolone in secondary progressive MS. Neurology (1999) 0.75
Laser photocoagulation for central serous retinopathy. Ophthalmology (1997) 0.75
Amaurosis fugax: controversies in management. Int Ophthalmol Clin (1986) 0.75
Moral attitude and suicidal behavior. Psychol Rep (1974) 0.75
The neuro-ophthalmic examination. Neurol Clin (1983) 0.75
Optic disc edema in the presumed ocular histoplasmosis syndrome. Ophthalmology (1984) 0.75
Postgadolinium enhancement of a compressive neuropathy of the optic nerve. AJNR Am J Neuroradiol (1995) 0.75
Retinitis pigmentosa. A mimic of neurologic disease. Surv Ophthalmol (1987) 0.75
Comparison of the ONTT intravenous group and the CHAMPS placebo group. J Neuroophthalmol (2001) 0.75
Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol (1984) 0.75
Computerized optic disk imaging techniques. Int Ophthalmol Clin (1986) 0.75
Optic nerve head drusen. Arch Ophthalmol (1984) 0.75
Third nerve palsy as a presenting sign of acquired immune deficiency syndrome. J Clin Neuroophthalmol (1987) 0.75
Sudden infant death syndrome: a literature review with chiropractic implications. J Manipulative Physiol Ther (1987) 0.75